OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 68 filers reported holding OVID THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,923,000 | -74.8% | 2,500,000 | 0.0% | 0.05% | -74.7% |
Q1 2024 | $7,625,000 | +94620.5% | 2,500,000 | 0.0% | 0.19% | -27.6% |
Q4 2023 | $8,050 | -16.1% | 2,500,000 | 0.0% | 0.27% | -35.0% |
Q3 2023 | $9,600 | +17.1% | 2,500,000 | 0.0% | 0.41% | +62.2% |
Q2 2023 | $8,200 | +27.1% | 2,500,000 | 0.0% | 0.25% | -33.7% |
Q1 2023 | $6,450 | +38.7% | 2,500,000 | 0.0% | 0.38% | +47.3% |
Q4 2022 | $4,650 | -99.9% | 2,500,000 | 0.0% | 0.26% | +32.7% |
Q3 2022 | $4,600,000 | -14.4% | 2,500,000 | 0.0% | 0.20% | -31.7% |
Q2 2022 | $5,375,000 | -31.5% | 2,500,000 | 0.0% | 0.29% | -12.8% |
Q1 2022 | $7,850,000 | -2.2% | 2,500,000 | 0.0% | 0.33% | +50.9% |
Q4 2021 | $8,025,000 | -4.5% | 2,500,000 | 0.0% | 0.22% | +16.0% |
Q3 2021 | $8,400,000 | -14.1% | 2,500,000 | 0.0% | 0.19% | -5.1% |
Q2 2021 | $9,775,000 | -2.7% | 2,500,000 | 0.0% | 0.20% | +11.2% |
Q1 2021 | $10,050,000 | +74.0% | 2,500,000 | 0.0% | 0.18% | +43.5% |
Q4 2020 | $5,775,000 | -59.8% | 2,500,000 | 0.0% | 0.12% | -64.4% |
Q3 2020 | $14,350,000 | – | 2,500,000 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,540,671 | $2,835,000 | 1.27% |
Madison Avenue Partners, LP | 1,394,022 | $2,565,000 | 0.55% |
BVF INC/IL | 6,851,051 | $12,606,000 | 0.52% |
CHI Advisors LLC | 864,822 | $1,591,000 | 0.43% |
Rubric Capital Management LP | 4,516,300 | $8,310,000 | 0.42% |
EcoR1 Capital, LLC | 6,117,400 | $11,256,000 | 0.33% |
Artal Group S.A. | 2,500,000 | $4,600,000 | 0.20% |
DCF Advisers, LLC | 162,701 | $299,000 | 0.19% |
Oasis Management Co Ltd. | 270,000 | $497,000 | 0.08% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 908,500 | $1,672,000 | 0.04% |